How do you maximize #PeripheralIVL treatment? Dr Kumar Madassery uses #IVUS to determine the location, type and amount of calcium, then often deploys #ShockwaveIVL. Watch now for more of his best practices. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveP2P
Shockwave Medical
Medical Equipment Manufacturing
Santa Clara, California 97,334 followers
Making waves for underserved patients with cardiovascular disease via novel technologies. ⚡🌊
About us
Shockwave Medical is revolutionizing the interventional treatment of advanced cardiovascular disease by developing technology that targets calcified plaque. Inspired by 30-years of safety and efficacy in kidney stone treatment, our Intravascular Lithotripsy family of catheters delivers localized lithotripsy at the site of cardiovascular calcium that enables gentle balloon dilatation of calcified, stenotic arteries. IVL catheters use sonic pressure waves to preferentially impact hard tissue, disrupting calcium, while leaving soft tissue undisturbed. An integrated balloon catheter then dilates the calcified lesion at low-pressure, restoring blood flow. Stay connected with us at www.ShockwaveMedical.com and on Twitter @ShockwaveIVL
- Website
-
http://shockwavemedical.com
External link for Shockwave Medical
- Industry
- Medical Equipment Manufacturing
- Company size
- 1,001-5,000 employees
- Headquarters
- Santa Clara, California
- Type
- Public Company
Locations
-
Primary
5403 Betsy Ross Dr
Santa Clara, California 95054, US
Employees at Shockwave Medical
-
Lori Dossola Lyle
Marketing at Shockwave Medical, Inc.
-
Erika Johnson
-
Bharath Natarajan
Senior Director, Data Platform and Business Intelligence
-
Jason Shields
Medical Device Executive | General Management | Commercial Execution | Marketing | Professional Education | Business Development | Digital Surgery
Updates
-
ROLLER COASTR-EPIC22 randomized trial findings further confirm #ShockwaveIVL’s proven safety and efficacy in treating heavily calcified coronary lesions. Read principal investigator Dr. Alfonso Jurado-Román, MD, PhD’s new JACC Journals paper to learn more: https://lnkd.in/gHssjg9k US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #RollerCoastrTrial
-
-
“When I think about calcium, I know I’m in for a battle.” Dr Leah Raj discusses coronary calcium challenges, modality selection, proper lesion prep, the crucial importance of intravascular imaging and more. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ShockwaveP2P
-
Reading the new ROLLER COASTR-EPIC22 paper in JACC Journals? Gain additional insights by watching Principal Investigator Dr Alfonso Jurado-Román, MD, PhD and #ShockwaveIVL CMO Dr Nick West discuss the trial’s findings: https://lnkd.in/gW2tZyXm US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #RollerCoastrTrial
-
-
In Dr. Alfonso Jurado-Román, MD, PhD's randomized ROLLER COASTR-EPIC22 trial, #ShockwaveIVL was determined to be noninferior to rotational atherectomy for coronary stent expansion — and IVL’s complications were numerically lower. Read the new JACC Journals publication for more insights: https://lnkd.in/gHssjg9k US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #RollerCoastrTrial
-
-
The EMPOWER CAD study is a prospective, multi-center, single-arm, all comers study to generate real-world clinical evidence associated with #CoronaryIVL in a population of female patients with calcified coronary artery disease (CAD). Drs Dean Kereiakes, Margaret McEntegart, Suzanne Baron & Robert Riley discuss the design and rationale of the #EMPOWERCAD study in this #SCAI CME-accredited webinar. Watch the conversation and claim CME credit here: https://lnkd.in/gdJJeBBg US Rx only. Important Safety Information: http://bit.ly/3iEq7fC Caution: Shockwave Coronary Javelin is an Investigational Device. Limited by Federal (or United States) law to investigational use.
-
-
This past quarter, we made waves that improved patient care. Read about new product releases, #ShockwaveIVL research and more in the latest edition of our PulsePoint Newsletter: https://lnkd.in/gXUJX6K5 US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
-
A packed house #PeripheralIVL symposium at #CRT2025! 🏛️ Thank you to Drs. George Adams, Peter Soukas, Sahil Parikh, Eric A. Secemsky, & J.D. Corl, for engaging presentations on #DisruptBTKII 30-day results, #ShockwaveE8 cases, the new #ShockwaveJavelin catheter, and more. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
-
We got cracking at our nation’s capital in the #ShockwaveIVL coronary imaging and calcium modification symposium at #CRT2025. Thank you to Drs. Jas Singh, Kevin Croce, Carlos Collet, Hector Tamez, and Evan Shlofmitz for leading the charge on discussing the latest in CCTA pre-PCI planning, the latest OCT catheter and highlighting our proven crack record. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC
-
-
The ROLLING STONE trial is the largest prospective investigator-initiated multicenter registry comparing the safety and efficacy of #ShockwaveIVL and atherectomy. The >1000 patient study presented at #CRT2025 by Dr. Enrico Cerrato reiterates the safety of #CoronaryIVL. The results confirm lower MACE rates with IVL versus atherectomy at 1 year. US Rx only. Important Safety Information: http://bit.ly/3iEq7fC #ROLLINGSTONEtrial
-